The Georgian House, 22/24 West End
Founded in 1944, NSF International’s mission is to protect and improve global human health. NSF International, Pharmaceutical Services provides a comprehensive range of independent, third-party pharmaceutical and biotech support services for the pharmaceutical industry. These services are delivered by some of the most knowledgeable experts in their fields. Whether you’re looking for pharmaceutical consulting, training, auditing or regulatory guidance, you can trust the experts at NSF International, Pharmaceutical Services.
Partnering with you to provide world-class regulatory and compliance consulting, auditing and pharmaceutical training on a global basis.
In this short video Martin Lush, Global Vice President of NSF Pharmaceutical Servicesand Medical Devices, gives an overview of our services and explains what makes NSF different from other providers:
Our unique combination of former regulatory agency staff and experienced industry professionals will assist you to achieve and maintain compliant, future-proof pharmaceutical quality systems (PQS) develop your staff at all levels to maximize their contribution to the business and help you to improve the competitive edge of your company in an increasingly complex and challenging marketplace. We are here to help get your products to market.
We care about you, our clients, which is why over 87% come back for more.
Providing you with solutions across the product life cycle:
Our ‘Not for Profit’ status means we act in your long-term best interest based on good science, expert experience and common sense.
We help you enhance and embed the right culture throughout your organization.
We also offer comprehensive medical devices consulting, training and auditing, and are able to assist companies in navigating international regulatory hurdles throughout the product lifestyle. We have combined regulatory and industry expertise across all therapeutic areas and provide customised consulting services in a number of areas. Click here to find out more.
Is Your Outsourcing Project Out of Mind and Out of Hand? download our most recent whitepaper
The latest issue of our Journal is out now. Entitled Changing Regulations - Here to Support You Wherever You Are, this edition focuses on the importance of adaptability in the health and life sciences industry.
Martin Lush highlights the importance of training and education to improve your business and John Johnson explains how to manage the risks associated with outsourcing.
Also in this issue, we take an in-depth look at the growth of biopharma and med tech in Ireland and how NSF supports this. We also cover the FDA’s Sentinel Initiative and its five-year strategic plan as well as the latest changes in the EU MDR. Click here to download our latest journal.
NSF International's Medical Devices team has developed a tool to help you ensure your in vitro diagnostic medical devices satisfy all the applicable general safety and performance requirements to demonstrate conformity with the IVDR. Click here to download the white paper.
Revealed: UK's rapid Covid test not yet approved by regulators | World news | The Guardian https://t.co/9fxMlll0HP— sarahboseley (@sarahboseley) August 7, 2020
Revealed: UK's rapid Covid test not yet approved by regulators https://t.co/LJYc7yhMHG— The Guardian (@guardian) August 7, 2020